Sanofi-aventis, MMV to launch largest antimalarial drug study
Friday, November 20, 2009 13:00 IST Paris, France
Sanofi-aventis and Medicines for Malaria Venture (MMV) announced that they have entered an agreement to launch the largest safety and efficacy study of an antimalarial drug.